Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Geoff Meacham

Recent news which mentions Geoff Meacham

Eli Lilly's Upcoming Obesity Drugs Highlight Bright Future, Says Optimistic Analyst
Tickers LLY
Tags Price Target Expert Ideas Movers
From Benzinga
Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock
Tickers BAC GILD
Tags BAC General Biotech
From Benzinga
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
Tickers MRK PFE
Tags General Price Target PFE
From Benzinga
7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%
Tickers BIIB
Tags Ami Fadia Benzinga Price Target
From Benzinga
Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
Tickers BHVN BNTX GBT PFE
Tags Wells Fargo General Stewart Glickman
From Benzinga
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
Tickers BNTX MRNA NVAX PFE
Tags Analyst Ratings SVB Securities BNTX
From Benzinga
10 Investor Questions About COVID-19, Answered
Tickers JNJ MRNA NVAX PFE
Tags NVAX General Benzinga
From Benzinga
Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market
Tickers GSK MRNA PFE SNY
Tags MRNA Analyst Color Geoff Meacham
From Benzinga
Why This Analyst Has Increased Confidence In Inovio Pharmaceuticals
Tickers INO
Tags Biotech Upgrades Benzinga
From Benzinga
BofA Downgrades CureVac On Limited 2022 Prospects
Tickers CVAC
Tags Global Analyst Ratings Market News
From Benzinga
BofA Bullish On This Gene Therapy Biotech Transitioning Into A Commercial Enterprise
Tickers KRYS
Tags Analyst Ratings Initiation Analyst Color
From Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
Tickers PFE REGN
Tags Analyst Ratings Analyst Color Downgrades
From Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
Tickers MRK PFE
Tags Paxlovid General Biotech
From Benzinga
3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat
Tickers ABBV AMGN JNJ LLY
Tags General Biotech Benzinga
From Benzinga
How To Play Moderna Stock Ahead Of Key FDA COVID-19 Booster Shot Ruling
Tickers MRNA PFE
Tags Geoff Meacham Market News MRNA
From Benzinga
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
Tickers BNTX JNJ MRK MRNA
Tags Coronavirus Reiteration JNJ
From Benzinga
Moderna Analysts Debate Need For Biopharma's COVID-19 Booster Shot
Tickers BNTX MRNA PFE
Tags Benzinga Biotech Covid/19
From Benzinga
Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA
Tickers RANI RXST
Tags RXST Initiation Analyst Ratings
From Benzinga
Moderna's Stock Valuation Goes From 'Unreasonable To Ridiculous': Analyst
Tickers AMGN BMY MRK MRNA
Tags vaccine General Biotech
From Benzinga
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
Tickers GENE GRPH
Tags Health Care Jeffrey Hung Gene Editing
From Benzinga
These 3 New Biotechs Have Differentiated Platforms, Technology: BofA
Tickers AMAM CYT IPSC
Tags Geoff Meacham Market News Analyst Color
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS